Skip to content

Intuitive Surgical Inc-September Highlights

Supportive Fundamentals The da Vinci Surgical System received CE mark approval in Europe, expanding its market access. Strong double-digit growth in robotic procedures indicates strong market demand for Intuitive's technology. FDA clearance of the Vessel Sealer Curved enhances product offerings and can lead to increased adoption. Analysts maintained strong estimates and price targets, despite recent stock price adjustments. Points of Caution The stock is rated as a 'Strong Sell' due to recent poor operational performance and high valuations. Deutsche Bank warns of risks associated with remanufactured instruments, potentially affecting product reliability. Recent earnings show pressure on margins due to rising costs and tariffs, leading to market skepticism. Insider selling by management raises potential concerns about confidence in the stock. Impacting Factors Analyst recommendations have shifted slightly negative amidst cost inflation concerns. Insider trading activity might signal a lack of confidence in future company performance. Growth potential remains high, but recent challenges may suppress investor sentiment. Technical Trend Technical Rating : Strong Sell Stop Loss : 5% Profit Potential : 2-4% Target Price : 450-460 Strategy Spotlight - (HA Scalping) All USD All % Long USD Long %
Enjoying the preview? The full article is just a click away. Subscribe now or log in to keep reading.

Leave a Reply

Your email address will not be published. Required fields are marked *

This report is generated using AI-based predictive models and market data analysis. It is intended solely for informational and educational purposes. The content should not be interpreted as investment advice, financial guidance, or a recommendation to buy or sell any financial instrument.

Trading financial instruments involves risk and may result in the loss of capital. Past performance is not indicative of future results. All trading decisions made based on this report are done at the user's own risk and discretion.

The creators and distributors of this report are not liable for any losses incurred.